NovoSeven® RT is proven effective to treat FVIId at home and is 93% effective at stopping nonsurgical and surgical bleeds in people with FVIId.a
Living with factor VII deficiency?
NovoSeven® RT has the proven effectiveness you expect from your treatment.

Controls bleeds, wherever they happen.
aFrom an analysis of published cases and people who took part in trials and registries.
![Chart: NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) was 93% effective at stopping nonsurgical and surgical bleeds in patients with congenital factor VII deficiency](/content/dam/novonordisk/novoseven/what-does-it-treat/FVII-deficiency-93-effective-chart.png)
Effectively control bleeds.
90% efficacy in bleed control in trial patients.


Portability that fits an active lifestyle.
NovoSeven® RT is room temperature stable up to 77°F, so you can be on the go.b And, with compact packaging, you can take it along where you need to go.
bNovoSeven® RT should be stored between 36°F and 77°F.
For complete storage information, please see Prescribing Information.
Quick to mix.c
NovoSeven® RT with MixPro® makes mixing a dose as easy as attach, twist, and mix. The prefilled syringe saves time—there are no extra steps to fill a syringe with diluent.
![Illustration: Preparing NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) Injection](/content/dam/novonordisk/novoseven/what-does-it-treat/preparing-NovoSeven®-RT-injection.png)
After mixing, NovoSeven® RT may be stored at room temperature in the vial for up to 3 hours.
cCompared with mixing using histidine vials.
Fast to infuse.
NovoSeven® RT provides low infusion volume, so infusing takes 2 to 5 minutes.d NovoSeven® RT is given as an intravenous (IV) bolus injection.
dAdminister as a slow bolus injection over 2 to 5 minutes, depending on the dose administered.
![Pie Chart: NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) takes 2 to 5 minutes to infuse](/content/dam/novonordisk/novoseven/what-does-it-treat/between-2-and-5-minutes.png)
Established safety profile that comes from experience.e
eCompassionate use, also known as expanded access, began enrolling in 1988; FDA approval received in 1999.

What if I need surgery or a procedure?
We understand that you have concerns about controlling bleeds if you ever need surgery or a procedure. The good news is that NovoSeven® RT prevents bleeds during and after surgery and procedures in people with FVIId.
Talk to your doctor for more information on the surgical use of NovoSeven® RT.

Hear from people who
share your experience.

New to treatment? It's
easy to get started.
![Icon: 5-step purification process of NovoSeven® RT (Coagulation Factor VIIa [Recombinant])](/content/dam/novonordisk/novoseven/cta/CTA-recombinant.jpg)